Explain the following processes involving chromosome mutations and cancer development.
How the chromosome mutation producing the Philadelphia chromosome leads to CML.

검증된 단계별 안내

Understand that the Philadelphia chromosome is a specific chromosomal abnormality resulting from a translocation between chromosome 9 and chromosome 22, denoted as t(9;22)(q34;q11).

Recognize that this translocation fuses part of the BCR gene from chromosome 22 with part of the ABL1 gene from chromosome 9, creating a novel fusion gene called BCR-ABL1.

Know that the BCR-ABL1 fusion gene encodes a constitutively active tyrosine kinase enzyme, which means it is always 'on' and continuously signals cells to proliferate.

Understand that this abnormal signaling leads to uncontrolled growth and division of myeloid cells in the bone marrow, disrupting normal blood cell production.

Connect this uncontrolled proliferation of myeloid cells to the development of chronic myelogenous leukemia (CML), a type of cancer characterized by excessive accumulation of these abnormal white blood cells.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.

영상 길이:

도움이 되었나요?

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Philadelphia Chromosome

The Philadelphia chromosome is a specific abnormal chromosome formed by a translocation between chromosomes 9 and 22. This translocation fuses the BCR gene from chromosome 22 with the ABL gene from chromosome 9, creating the BCR-ABL fusion gene, which produces an abnormal tyrosine kinase protein.

Chromosome Mutation and Translocation

Chromosome translocation is a mutation where segments from two different chromosomes swap places. This can disrupt normal gene function or create fusion genes, leading to altered cellular behavior. In the case of the Philadelphia chromosome, this mutation activates oncogenic pathways.

Chronic Myelogenous Leukemia (CML) Development

CML is a type of cancer caused by the uncontrolled proliferation of white blood cells due to the BCR-ABL fusion protein's constant tyrosine kinase activity. This abnormal signaling promotes cell division and inhibits apoptosis, leading to leukemia progression.

Explain the following processes involving chromosome mutations and cancer development.How the chromosome mutation producing the Philadelphia chromosome leads to CML.